PAPER Heiman M, Heilbut A, Francardo V, Kulicke R, Fenster RJ, Kolaczyk ED, Mesirov JP, Surmeier DJ, Cenci MA, Greengard P
SEARCH RESULTS
330986 RESULTS
PAPER Kita T, Asanuma M, Miyazaki I, Takeshima M
Protective effects of phytochemical antioxidants against neurotoxin-induced degeneration of dopaminergic neurons.
J Pharmacol Sci. 2014;124(3):313-9. Epub 2014 Mar 4 PubMed: 24599140PAPER Rana A, Saeed U, Masroor MS, Yousuf MS, Siddiqui I
A cross-sectional study investigating clinical predictors and physical experiences of pain in Parkinson's disease.
Funct Neurol. 2013 Oct-Dec;28(4):297-304. PubMed: 24598399PAPER Gao Z, Fu HJ, Xue JJ, Wu ZX, Zhao LB
Genetic polymorphisms in VDR, ESR1 and ESR2 genes may contribute to susceptibility to Parkinson's disease: a meta-analysis.
Mol Biol Rep. 2014 Mar 5; PubMed: 24595449PAPER Peterson DS, Pickett KA, Duncan R, Perlmutter J, Earhart GM
Gait-related brain activity in people with Parkinson disease with freezing of gait.
PLoS One. 2014;9(3):e90634. Epub 2014 Mar 3 PubMed: 24595265PAPER Zhao Y, Zheng X, Wang Q, Xu J, Xu X, Zhang M
Altered activation in visual cortex: unusual functional magnetic resonance imaging finding in early Parkinson's disease.
J Int Med Res. 2014 Apr;42(2):503-15. Epub 2014 Mar 4 PubMed: 24595154PAPER Daviet JC, Roy X, Quelven-Bertin I, Jallageas R, Mandigout S, Torny F, Monteil J
Parkinson's patient runs an ultra marathon: a case report.
Eur J Phys Rehabil Med. 2014 Mar 5; PubMed: 24594852PAPER Vedam-Mai V, Gardner B, Okun MS, Siebzehnrubl FA, Kam M, Aponso P, Steindler DA, Yachnis AT, Neal D, Oliver BU, Rath SJ, Faull RL, Reynolds BA, Curtis MA
Increased precursor cell proliferation after deep brain stimulation for Parkinson's disease: a human study.
PLoS One. 2014;9(3):e88770. Epub 2014 Mar 3 PubMed: 24594681PAPER Weiduschat N, Mao X, Beal MF, Nirenberg MJ, Shungu DC, Henchcliffe C
Sex differences in cerebral energy metabolism in Parkinson's disease: a phosphorus magnetic resonance spectroscopic imaging study.
Parkinsonism Relat Disord. 2014 May;20(5):545-8. Epub 2014 Feb 13 PubMed: 24593902PAPER Geevarghese R, Lumsden DE, Hulse N, Samuel M, Ashkan K
Subcortical Structure Volumes and Correlation to Clinical Variables in Parkinson's Disease.
J Neuroimaging. 2014 Mar 5; PubMed: 24593221PAPER Chen H, Jacobs E, Schwarzschild MA, McCullough ML, Calle EE, Thun MJ, Ascherio A
Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease.
Ann Neurol. 2005 Dec;58(6):963-7. PubMed: 16240369PAPER Meyer U, Feldon J, Yee BK
A review of the fetal brain cytokine imbalance hypothesis of schizophrenia.
Schizophr Bull. 2009 Sep;35(5):959-72. Epub 2008 Apr 11 PubMed: 18408229PSEN1 A275V
MUTATIONS PSEN1 73664793 GRCh37/hg19 C T Exon 8 Point, Missense Coding Increased the Aβ42/Aβ40 ratio and decreased the Aβ (37 + 38 + 40) / (42 + 43) ratio. Neuropathology consistent with AD. A275V Alzheimer's Disease: PathogenicAlzheimer's Disease This mu
Mindy Brown
South Orange, United States
APP
ANTIBODY polyclonal manufacturer Synthetic peptide GYENPTYKFFEQMQN corresponding to the C-terminus of APP coupled to key-hole limpet hemocyanin via an added N-terminal cysteine residue. antiserum, lyophilized. Specific for APP. Confirmed available March 2014 127 0
Current Filters
No filters selected